drugset / Trial / NCT07489482

A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

NCT07489482

Phase 1 Recruiting 60 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a randomized, parallel, open-label Phase I clinical trial aimed at comparing the bioavailability and safety of different specifications of SHR-3167 injection, with healthy subjects as the research subjects.

Timeline

Start
2026-04-02
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR-3167 Unknown

Indications